1,839
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Design and simulation of novel laparoscopic renal denervation system: a feasibility study

ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 9-18 | Received 11 Dec 2017, Accepted 17 Apr 2018, Published online: 18 May 2018

References

  • Calhoun DA, et al. Resistant hypertension: diagnosis, evaluation, and treatment. Circulation. 2008;117:e510–e526.
  • Nwankwo T, et al. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013;133:1–8.
  • World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization; 2009.
  • Smith PA, et al. Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertension. 2004;17:217–222.
  • Dibona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertension. 2002;11:197–200.
  • Wyss JM. The role of the sympathetic nervous system in hypertension. Curr Opin Nephrol Hypertension. 1993;2:265–273.
  • Rodrigues AFDAC, de Lima ILB, Bergamaschi CT, et al. Increased renal sympathetic nerve activity leads to hypertension and renal dysfunction in offspring from diabetic mothers. Am J Physiol Renal Physiol. 2013;304:F189–F197.
  • Newcombe CP, Shucksmith HS, Suffern WS. Sympathectomy for hypertension. BMJ. 1959;1:142.
  • Allen EV. Sympathectomy for essential hypertension. Circulation. 1952;6:131–140.
  • Smithwick RH. Surgical treatment of hypertension. Am J Med. 1948;4:744–759.
  • Morrissey DM, Brookes V, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet. 1953;1:403–408.
  • Schlaich MP, Sobotka PA, Krum H, et al. Renal denervation as a therapeutic approach for hypertension. Hypertension. 2009;54:1195–1201.
  • Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–1281.
  • Dibona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R245–R253.
  • Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932–934.
  • Bhatt DL, Kandzari DE, O'neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–1401.
  • Vink EE, Goldschmeding R, Vink A, et al. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study. Nephrol Dial Transplant. 2014;29:1608–1610.
  • Atherton DS, Deep NL, Mendelsohn FO. Micro‐anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat. 2012;25:628–633.
  • WH, Song, et al. Analysis of anatomical distribution of renal sympathetic nerve fibers and 3D phantom modeling: Study using nephrectomy specimens. Paper presented at: 2017 Annual Meeting of The Korean Urological Association; 2017 Sep 27-29; Seoul, Korea.
  • Gerber RC, Bahler CD, Kraus MA, et al. Laparoscopic renal denervation for uncontrolled hypertension due to medication intolerance: a case report. Am J Kidney Dis. 2016;68:131–133.
  • Chung DDL. Electromagnetic interference shielding effectiveness of carbon materials. Carbon. 2001;39:279–285.
  • Bonsib SM. Renal veins and venous extension in clear cell renal cell carcinoma. Mod Pathol. 2007;20:44–53.
  • Kanai T, Krum H. New treatment for old disease: management of resistant hypertension by percutaneous renal sympathetic denervation. Revista Española de Cardiología (English Ed.). 2013;66:734–740.
  • Neufeld E, Kyriakou A, Sharma D, et al. Modeling, effect prediction, and planning for EM-and FUS-based thermal treatment. The 8th European Conference on Antennas and Propagation (EuCAP); 2014 April 6-11; Hague: Netherlands. 2014;1483–1487.
  • Plonsey R, Heppner DB. Considerations of quasi-stationarity in electrophysiological systems. Bull Mathemat Biophysics. 1967;29:657–664.
  • Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J. Appl. Physiol. 1948;85:5–34.
  • Collins CM, Liu W, Wang J, et al. Temperature and SAR calculations for a human head within volume and surface coils at 64 and 300 MHz. J Magn Reson Imaging. 2004;19:650–656.
  • IEEE Standard for Safety Levels with Respect to Human Exposure to Radio Frequency Electromagnetic Fields, 3 kHz to 300 GHz. IEEE C95.1-2005. Piscataway, NJ: IEEE Standards Association, 2005
  • Lounsberry W, Goldschmidt V, Linke CA, et al. The early histologic changes following electrocoagulation. J Urol. 1961;86:321–329.
  • Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev. 2010;90:513–557.
  • Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1–S7.
  • Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559–565.
  • Böhm M, Linz D, Ukena C, et al. Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond? Circul Res. 2014;115:400–409.